Scinovex
reviewTop 1% cited

BODIPY dyes in photodynamic therapy

Chemical Society Reviews · 2012 · Vol. 42(1) · pp. 77–88
Anyanee KamkaewSiang Hui LimHong Boon LeeLik Voon KiewLip Yong ChungKevin Burgess

Abstract

BODIPY dyes tend to be highly fluorescent, but their emissions can be attenuated by adding substituents with appropriate oxidation potentials. Substituents like these have electrons to feed into photoexcited BODIPYs, quenching their fluorescence, thereby generating relatively long-lived triplet states. Singlet oxygen is formed when these triplet states interact with 3O2. In tissues, this causes cell damage in regions that are illuminated, and this is the basis of photodynamic therapy (PDT). The PDT agents that are currently approved for clinical use do not feature BODIPYs, but there are many reasons to believe that this situation will change. This review summarizes the attributes of BODIPY dyes for PDT, and in some related areas.

Nanoplatforms for cancer theranosticsLuminescence and Fluorescent MaterialsPhotodynamic Therapy Research StudiesBODIPYPhotodynamic therapySinglet oxygenPhotochemistryQuenching (fluorescence)ChemistryFluorescenceSinglet stateRose bengalPorphyrin
Citations
2,028
FWCI
56.66
field-weighted impact
References
77
Percentile
100%
vs. same field & year
Citations per year
Cited by
References
Photodynamic therapy for cancer
Nature reviews. Cancer · 2003 · 6,614 citations
Fluorescent indicators based on BODIPY
Chemical Society Reviews · 2011 · 2,218 citations
The chemistry of Bodipy: A new El Dorado for fluorescence tools
New Journal of Chemistry · 2007 · 928 citations
The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed
Angewandte Chemie International Edition · 2007 · 3,075 citations
Photodynamic therapy of cancer: An update
CA A Cancer Journal for Clinicians · 2011 · 5,066 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.